Vitrolife AB (publ) (OTCMKTS:VTRLY – Get Free Report) was the recipient of a significant growth in short interest in April. As of April 30th, there was short interest totaling 43 shares, a growth of 330.0% from the April 15th total of 10 shares. Based on an average trading volume of 6 shares, the days-to-cover ratio is presently 7.2 days.
Vitrolife AB (publ) Price Performance
VTRLY stock opened at $11.00 on Wednesday. Vitrolife AB has a one year low of $9.50 and a one year high of $18.55. The company’s 50 day moving average price is $10.88 and its two-hundred day moving average price is $13.69.
Vitrolife AB (publ) Company Profile
Vitrolife AB (publ) is a Sweden‐based life science company specializing in products and systems for in vitro fertilization (IVF) and assisted reproductive technologies. Founded in 1994 and headquartered in Gothenburg, the company develops, manufactures and markets a comprehensive portfolio of consumables, culture media and instruments that support the entire IVF process, from gamete handling to embryo culture and cryopreservation.
The company’s product range includes embryo culture media, blastocyst media, vitrification solutions and pipetting tools designed to optimize laboratory workflows and improve outcomes for fertility clinics and patients.
Featured Articles
- Five stocks we like better than Vitrolife AB (publ)
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Vitrolife AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitrolife AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
